Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder
type: MedicalStudy
description: A Multicenter, Randomized, Double-Blind, Placebo and Escitalopram Controlled Trial of the Safety and Efficacy of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE1,PHASE2
start date: 2005-11
end date: 2007-10
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00135421
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Bristol-Myers Squibb
study subject: Major Depressive Disorder
keywords: PHASE1,PHASE2
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Major Depressive Disorder

AI Analytics
type: Organization